BioSpace News Archive

ProciseDx Inc. announced today that it has received CE mark for its infliximab (Procise IFX™) and adalimumab (Procise ADL™) point of care tests for use on the ProciseDx™ system. Previously, patients and physicians had to wait up to one week for drug level test results which delayed dose adjustment for 2 to 6 weeks. Each test provid

Versatope Therapeutics, Inc., a biotechnology company developing vaccines and therapeutics, announced today that it has been awarded a Phase 1 Small Business and Innovation Award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH) to develop a novel vaccine

Together with leading industry partners, Getinge is showcasing innovative connectivity solutions for creating a more quiet and healing environment for the intensive care unit.

Relias , a trusted partner to more than 11,000 healthcare clients globally, will release its third edition of the State of Training & Staff Development Report at its premier healthcare conference, Impact Nation , September 15-16, 2020 . The re

The clinical trial results demonstrate clearly that PrimeC, NeuroSense’s combination drug, has significant therapeutic potential for amyotrophic lateral sclerosis (ALS) patients. [09-September-2020] HERZLIYA, Israel , Sept. 9, 2020 /PRNewswire/ -- NeuroSense Therapeutics , a Biotech company developing PrimeC, a combination drug which aims to slow ALS progression, ann

Data presented at the Women in Ophthalmology 2020 Virtual Summer Symposium show the novel eyelid procedure successfully achieved clinically meaningful reductions in signs and symptoms of dry eye [09-September-2020] MENLO PARK, Calif. , Sept. 9, 2020 /PRNewswire/ -- Sight Sciences, Inc. , a growth-stage ophthalmic medical device company, today announced further favorabl

Today PAX Labs announced the launch of its award-winning PAX 3 cannabis vaporizer for dry herb and concentrates in a sleek and sophisticated new color palette that includes Onyx, Sand, Sage and Burgundy in a premium matte finish.

- Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scale - Ampion-treated patients showed greater improvement compared to patients treated with the standard of care including anti-viral therapies - Ampion found to be safe and well-tolerated with no drug related adverse events

ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Morgan Stanley 18 th Annual Global Healthcare Conference on Monday, September 14, 2020, beginning at approximately 12:45 p.m. (Eastern Daylight Time) via video webcast.

- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its participation at two upcoming virtual investor conferences. Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, is scheduled to participate in fireside chats during the following conferences: The H.C. Wainwright 22nd Annual Global Investment Conference – fireside chat scheduled to take place on Monday, September 14, 2020 at 1:30 PM ET The Cantor Fitzgerald Globa